CK Life Sciences Int'l., (Holdings) Inc. (0775.HK)
HKD 0.52
(-1.89%)
HKD 0.52
(-1.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.05 Billion HKD | -0.75% |
| 2022 | 7.11 Billion HKD | -1.64% |
| 2021 | 7.23 Billion HKD | -0.4% |
| 2020 | 7.25 Billion HKD | 11.0% |
| 2019 | 6.53 Billion HKD | 8.66% |
| 2018 | 6.01 Billion HKD | 3.29% |
| 2017 | 5.82 Billion HKD | 14.63% |
| 2016 | 5.08 Billion HKD | -3.31% |
| 2015 | 5.25 Billion HKD | -3.04% |
| 2014 | 5.42 Billion HKD | 8.03% |
| 2013 | 5.01 Billion HKD | 40.36% |
| 2012 | 3.57 Billion HKD | 12.54% |
| 2011 | 3.17 Billion HKD | 79.93% |
| 2010 | 1.76 Billion HKD | -3.07% |
| 2009 | 1.82 Billion HKD | 0.17% |
| 2008 | 1.81 Billion HKD | 8.7% |
| 2007 | 1.67 Billion HKD | 72.57% |
| 2006 | 969.63 Million HKD | 8.12% |
| 2005 | 896.79 Million HKD | 311.72% |
| 2004 | 217.81 Million HKD | 370.53% |
| 2003 | 46.29 Million HKD | 85.75% |
| 2002 | 24.92 Million HKD | -94.35% |
| 2001 | 441.13 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 6.87 Billion HKD | 0.0% |
| 2023 Q2 | 6.88 Billion HKD | 0.0% |
| 2023 FY | 7.05 Billion HKD | -0.75% |
| 2023 Q4 | 7.05 Billion HKD | 0.0% |
| 2022 Q4 | 7.11 Billion HKD | 0.0% |
| 2022 FY | 7.11 Billion HKD | -1.64% |
| 2022 Q2 | 7.09 Billion HKD | 0.0% |
| 2021 Q4 | 7.23 Billion HKD | 0.0% |
| 2021 Q2 | 7.12 Billion HKD | 0.0% |
| 2021 FY | 7.23 Billion HKD | -0.4% |
| 2020 FY | 7.25 Billion HKD | 11.0% |
| 2020 Q2 | 6.61 Billion HKD | 0.0% |
| 2020 Q4 | 7.25 Billion HKD | 0.0% |
| 2019 FY | 6.53 Billion HKD | 8.66% |
| 2019 Q2 | 6.12 Billion HKD | 0.0% |
| 2019 Q4 | 6.53 Billion HKD | 0.0% |
| 2018 Q4 | 6.01 Billion HKD | 0.0% |
| 2018 FY | 6.01 Billion HKD | 3.29% |
| 2018 Q2 | 5.98 Billion HKD | 0.0% |
| 2017 Q4 | 5.82 Billion HKD | 0.0% |
| 2017 Q2 | 5.16 Billion HKD | 0.0% |
| 2017 FY | 5.82 Billion HKD | 14.63% |
| 2016 FY | 5.08 Billion HKD | -3.31% |
| 2016 Q4 | 5.08 Billion HKD | 0.0% |
| 2016 Q2 | 5.27 Billion HKD | 0.0% |
| 2015 Q4 | 5.25 Billion HKD | 0.0% |
| 2015 Q2 | 5.28 Billion HKD | 0.0% |
| 2015 FY | 5.25 Billion HKD | -3.04% |
| 2014 FY | 5.42 Billion HKD | 8.03% |
| 2014 Q4 | 5.42 Billion HKD | 0.0% |
| 2014 Q2 | 5.14 Billion HKD | 0.0% |
| 2013 Q2 | 4.64 Billion HKD | 0.0% |
| 2013 Q4 | 5.01 Billion HKD | 0.0% |
| 2013 FY | 5.01 Billion HKD | 40.36% |
| 2012 Q2 | 3.64 Billion HKD | 0.0% |
| 2012 Q4 | 3.57 Billion HKD | 0.0% |
| 2012 FY | 3.57 Billion HKD | 12.54% |
| 2011 Q4 | 3.17 Billion HKD | 0.0% |
| 2011 FY | 3.17 Billion HKD | 79.93% |
| 2011 Q2 | 3.13 Billion HKD | 0.0% |
| 2010 FY | 1.76 Billion HKD | -3.07% |
| 2010 Q2 | 1.76 Billion HKD | 0.0% |
| 2010 Q4 | 1.76 Billion HKD | 0.0% |
| 2009 FY | 1.82 Billion HKD | 0.17% |
| 2009 Q4 | 1.82 Billion HKD | 0.0% |
| 2008 FY | 1.81 Billion HKD | 8.7% |
| 2007 FY | 1.67 Billion HKD | 72.57% |
| 2006 FY | 969.63 Million HKD | 8.12% |
| 2005 FY | 896.79 Million HKD | 311.72% |
| 2004 FY | 217.81 Million HKD | 370.53% |
| 2003 FY | 46.29 Million HKD | 85.75% |
| 2002 FY | 24.92 Million HKD | -94.35% |
| 2001 FY | 441.13 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 152.81 Million HKD | -4518.669% |